Latest Schedule 13D activist filings

Norman D. Schwartz consolidates control of Bio-Rad Laboratories' Class B Common Stock following the death of Alice N. Schwartz, becoming the sole trustee of key family trusts.

Norman D. Schwartz assumes sole trustee roles for significant Bio-Rad Laboratories, Inc. Class A Common Stock trusts following the passing of Alice N. Schwartz, consolidating family control.

Figma CEO Dylan Field filed a Schedule 13D, disclosing beneficial ownership of 17.8% of Class A Common Stock, primarily due to vested equity awards and voting proxies.

The Public Employees Retirement System of Ohio has increased its beneficial ownership in KOREA FUND INC to 5.8%, holding 241,191 shares for investment purposes.

Jakota Games & Reels SAS, controlled by Norman Hansen, reduced its stake in Crisp Momentum Inc. by selling 50 million shares to a non-affiliated third party.

Ohio Public Employees Retirement System (OPERS) has reduced its beneficial ownership in Taiwan Fund Inc. to 4.88%, falling below the 5% reporting threshold.

Mir Imran, a key insider, increased his stake in Rani Therapeutics through a private placement, alongside proposed significant corporate governance changes.

North York Ltd. and Ashwood Leon Forbes have significantly increased their beneficial ownership in Earlyworks Co., Ltd., securing board nomination rights and driving a strategic acquisition.

Saba Capital Management, L.P. and its affiliates increased their beneficial ownership in The Mexico Fund, Inc. to 10.66% through recent open market purchases.

RA Capital Management and its affiliates reported a reduction in their beneficial ownership of VOR Biopharma Inc. common stock to 17.3% through recent open market sales.

Encompass Capital Advisors and Todd J. Kantor have updated their beneficial ownership in T1 Energy Inc. to approximately 19.99% of common stock.

Theodore Ralston, a director of General Enterprise Ventures, Inc., has increased his beneficial ownership to 27.0% of the company's common stock through conversions and a recent preferred stock purchase.

Trilogy Metals Inc.'s President and CEO, Tony Giardini, reported a beneficial ownership of 5.0% of the company's common shares as of March 1, 2024, projected to increase to 6.4% by October 19, 2025.

Miles Pelham and Rhino Ventures increase their beneficial ownership in Diginex Ltd to 69.5% through warrant exercise and internal transfers.

OrbiMed Advisors and OrbiMed Capital GP V have reduced their beneficial ownership in PMV Pharmaceuticals, Inc. to 9.4% through recent share sales.

Voss Capital and its affiliates have significantly reduced their beneficial ownership in International Money Express, Inc., now holding 2.6% of outstanding shares.

Copley Square LLC and affiliates report a 21.1% beneficial ownership in Harvard Ave Acquisition Corp following an IPO and private placement.

Northlake Partners Ltd. and Tian Wang have reported a beneficial ownership of 7.8% in Harvard Ave Acquisition Corp., totaling 1,604,757 ordinary shares.

Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC increased their beneficial ownership in Viridian Therapeutics, Inc. to 15.14% through a recent public offering.

Robert Nistico, CEO and Chairman of Splash Beverage Group, Inc., reported beneficial ownership of 7.1% of the company's common stock, primarily through warrants and options.

Augusta Investments Inc. and Richard Warke report the disposition of all Augusta Gold Corp. shares following its acquisition by AngloGold Ashanti for C$1.70 per share.

Lucky Dog Holdings has acquired a 19.2% beneficial ownership in BONK, INC. through convertible preferred stock, aiming for a controlling interest and board representation.

Michael Heinrich and Zero Gravity Labs Inc. have acquired beneficial ownership of 87.0% of Flora Growth Corp.'s common shares through a $150 million convertible note.

Trian Fund Management and General Catalyst propose to acquire all outstanding shares of Janus Henderson Group plc not currently owned by Trian for $46.00 per share in cash.

Yunqi Capital and its affiliates, holding 5.1% of STAAR Surgical, publicly urged the company's board to proceed with a stockholder vote on the Proposed Merger, opposing any further adjournment or rushed sales process.

WE-INN LLC and its affiliates have reduced their beneficial ownership in Innventure, Inc. to 14.37% through recent open market sales.

Broadwood Partners, a significant shareholder in STAAR Surgical Co., has formally demanded appraisal rights for its 27.4% stake in opposition to the proposed merger.

A group of significant shareholders in Brera Holdings PLC has dissolved their collective ownership, with several members joining the company's Board of Directors and participating in a PIPE offering.

Perceptive entities propose converting significant debt and contingent obligations of Trinity Biotech plc into equity, aiming to reduce cash outflows for the issuer.

Tether Holdings, S.A. de C.V. and its affiliates have disclosed an acquisition of 5.5% of Metalla Royalty & Streaming Ltd.'s common shares for investment purposes.